Evidence map›Paper›PMID 28988849›Full record

ReviewTrends in molecular medicine2017

Oxygen, Metabolism, and Regeneration: Lessons from Mice.

Ellen Heber-Katz

Abstract readReview
In one paragraph

Review in Trends in molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Hyperplastic Human Macromass Cartilage for Joint Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. Emerging roles of mitochondria in animal regeneration.Cell regeneration (London, England) · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Metabolic Reconfiguration Activates Stemness and Immunomodulation of PDLSCs.International journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ellen Heber-KatzLaboratory of Regenerative Medicine, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA. Electronic address: heberkatz@limr.org.

Funding

Regenerative wound healing via inflammation-modulating biomaterialsR01DE021104 · NIDCR · WISTAR INSTITUTE · PI Georgios Hajishengallis, Ellen s. Heber-Katz · 2011 to 2026
$8.5M
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?R01CA180070 · NCI · WISTAR INSTITUTE · PI HEBER-KATZ, ELLEN S., PURE', ELLEN · 2013 to 2016
$1.4M
Does Inflammation Enhance Rengeneration?R01DE021215 · NIDCR · WISTAR INSTITUTE · PI HEBER-KATZ, ELLEN S., MESSERSMITH, PHILLIP B · 2010 to 2013
$1.3M
NCI NIH HHS R01 CA180070NIDCR NIH HHS R01 DE021104NIDCR NIH HHS R01 DE021215
6 · The paper itself

Abstract

The discovery that the Murphy Roths Large (MRL) mouse strain is a fully competent, epimorphic tissue regenerator, proved that the machinery of regeneration was preserved through evolution from hydra, to salamanders, to mammals. Such concepts have allowed translation of the biology of amphibians, and their ability to regenerate, to a mammalian context. We identified the ancient hypoxia-inducible factor (HIF)-1α pathway, operating through prolyl hydroxylase domain proteins (PHDs), as a central player in mouse regeneration. Thus, the possibility of targeting PHDs or other HIF-1α modifiers to effectively recreate the amphibian regenerative state has emerged. We posit that these regenerative pathways are critical in mammals. Moreover, the current approved use of PHD inhibitors in the clinic should allow fast-track translation from mouse studies to drug-based regenerative therapy in humans.

Indexed as

AnimalsHumansHypoxia-Inducible Factor 1, alpha SubunitMiceOxygenRegenerationHypoxia-Inducible Factor 1, alpha SubunitOxygen

Identifiers

PMID28988849
PMCPMC5687987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.